(Q43996957)

28 November 2017

title

Pharmacokinetics of lovastatin extended-release dosage form (Lovastatin XL) in healthy volunteers (English)

1 reference

28 November 2017

1 reference

Michael Lamson

1

1 reference

28 November 2017

Gale Phillips

2

1 reference

28 November 2017

Jason Shen

3

1 reference

28 November 2017

Peter Lukacsko

4

1 reference

28 November 2017

Lawrence Friedhoff

5

1 reference

28 November 2017

Robert M Niecestro

6

1 reference

28 November 2017

publication date

1 May 2002

1 reference

Biopharmaceutics and Drug Disposition

28 November 2017

published in

1 reference

28 November 2017

volume

23

1 reference

28 November 2017

issue

4

1 reference

28 November 2017

page(s)

143-149

1 reference

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

28 November 2017

cites work

1 reference

Discovery, biochemistry and biology of lovastatin

21 January 2018

1 reference

Dose response, safety, and efficacy of an extended-release formulation of lovastatin in adults with hypercholesterolemia

21 January 2018

1 reference

Comparative pharmacokinetics of lovastatin extended-release tablets and lovastatin immediate-release tablets in humans

21 January 2018

1 reference

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

21 January 2018

1 reference

New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase

21 January 2018

1 reference

Enhancement of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/BDD.304

1 reference

28 November 2017

1 reference